Literature DB >> 27840052

Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.

Robert L Bowman1, Florian Klemm2, Leila Akkari2, Stephanie M Pyonteck3, Lisa Sevenich3, Daniela F Quail3, Surajit Dhara4, Kenishana Simpson3, Eric E Gardner5, Christine A Iacobuzio-Donahue6, Cameron W Brennan7, Viviane Tabar7, Philip H Gutin7, Johanna A Joyce8.   

Abstract

Extensive transcriptional and ontogenetic diversity exists among normal tissue-resident macrophages, with unique transcriptional profiles endowing the cells with tissue-specific functions. However, it is unknown whether the origins of different macrophage populations affect their roles in malignancy. Given potential artifacts associated with irradiation-based lineage tracing, it remains unclear if bone-marrow-derived macrophages (BMDMs) are present in tumors of the brain, a tissue with no homeostatic involvement of BMDMs. Here, we employed multiple models of murine brain malignancy and genetic lineage tracing to demonstrate that BMDMs are abundant in primary and metastatic brain tumors. Our data indicate that distinct transcriptional networks in brain-resident microglia and recruited BMDMs are associated with tumor-mediated education yet are also influenced by chromatin landscapes established before tumor initiation. Furthermore, we demonstrate that microglia specifically repress Itga4 (CD49D), enabling its utility as a discriminatory marker between microglia and BMDMs in primary and metastatic disease in mouse and human. Copyright Â
© 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD49D; Macrophage; brain metastasis; glioma; microglia; tumor-associated macrophages

Mesh:

Substances:

Year:  2016        PMID: 27840052      PMCID: PMC5450644          DOI: 10.1016/j.celrep.2016.10.052

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  58 in total

Review 1.  The complement system: an unexpected role in synaptic pruning during development and disease.

Authors:  Alexander H Stephan; Ben A Barres; Beth Stevens
Journal:  Annu Rev Neurosci       Date:  2012       Impact factor: 12.449

2.  All hematopoietic cells develop from hematopoietic stem cells through Flk2/Flt3-positive progenitor cells.

Authors:  Scott W Boyer; Aaron V Schroeder; Stephanie Smith-Berdan; E Camilla Forsberg
Journal:  Cell Stem Cell       Date:  2011-07-08       Impact factor: 24.633

3.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

4.  Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Authors:  Konrad Gabrusiewicz; Benjamin Rodriguez; Jun Wei; Yuuri Hashimoto; Luke M Healy; Sourindra N Maiti; Ginu Thomas; Shouhao Zhou; Qianghu Wang; Ahmed Elakkad; Brandon D Liebelt; Nasser K Yaghi; Ravesanker Ezhilarasan; Neal Huang; Jeffrey S Weinberg; Sujit S Prabhu; Ganesh Rao; Raymond Sawaya; Lauren A Langford; Janet M Bruner; Gregory N Fuller; Amit Bar-Or; Wei Li; Rivka R Colen; Michael A Curran; Krishna P Bhat; Jack P Antel; Laurence J Cooper; Erik P Sulman; Amy B Heimberger
Journal:  JCI Insight       Date:  2016-02-25

5.  Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

Authors:  Christopher N Parkhurst; Guang Yang; Ipe Ninan; Jeffrey N Savas; John R Yates; Juan J Lafaille; Barbara L Hempstead; Dan R Littman; Wen-Biao Gan
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

6.  The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.

Authors:  Alejandro Villagra; Fengdong Cheng; Hong-Wei Wang; Ildelfonso Suarez; Michelle Glozak; Michelle Maurin; Danny Nguyen; Kenneth L Wright; Peter W Atadja; Kapil Bhalla; Javier Pinilla-Ibarz; Edward Seto; Eduardo M Sotomayor
Journal:  Nat Immunol       Date:  2008-11-16       Impact factor: 25.606

7.  Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo.

Authors:  Jonathan K Alder; Robert W Georgantas; Richard L Hildreth; Ian M Kaplan; Sebastien Morisot; Xiaobing Yu; Michael McDevitt; Curt I Civin
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

8.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.

Authors:  Rose Du; Kan V Lu; Claudia Petritsch; Patty Liu; Ruth Ganss; Emmanuelle Passegué; Hanqiu Song; Scott Vandenberg; Randall S Johnson; Zena Werb; Gabriele Bergers
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

9.  Oligodendrocyte progenitor cells promote neovascularization in glioma by disrupting the blood-brain barrier.

Authors:  Yujie Huang; Caitlin Hoffman; Prajwal Rajappa; Joon-Hyung Kim; Wenhuo Hu; Jason Huse; Zhongshu Tang; Xuri Li; Babette Weksler; Jacqueline Bromberg; David C Lyden; Jeffrey P Greenfield
Journal:  Cancer Res       Date:  2013-12-26       Impact factor: 12.701

10.  Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks.

Authors:  Michaël Chopin; Cyril Seillet; Stéphane Chevrier; Li Wu; Hongsheng Wang; Herbert C Morse; Gabrielle T Belz; Stephen L Nutt
Journal:  J Exp Med       Date:  2013-11-18       Impact factor: 14.307

View more
  192 in total

Review 1.  Macrophages: The Road Less Traveled, Changing Anticancer Therapy.

Authors:  Jennifer L Guerriero
Journal:  Trends Mol Med       Date:  2018-04-11       Impact factor: 11.951

2.  Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.

Authors:  Wouter B L van den Bossche; Anne Kleijn; Charlotte E Teunissen; Jane S A Voerman; Cristina Teodosio; David P Noske; Jacques J M van Dongen; Clemens M F Dirven; Martine L M Lamfers
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

3.  Does niche competition determine the origin of tissue-resident macrophages?

Authors:  Martin Guilliams; Charlotte L Scott
Journal:  Nat Rev Immunol       Date:  2017-05-02       Impact factor: 53.106

Review 4.  A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.

Authors:  Hila Doron; Tobias Pukrop; Neta Erez
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

5.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

Review 6.  CAR T cells and checkpoint inhibition for the treatment of glioblastoma.

Authors:  Steven H Shen; Karolina Woroniecka; Andrew B Barbour; Peter E Fecci; Luis Sanchez-Perez; John H Sampson
Journal:  Expert Opin Biol Ther       Date:  2020-02-17       Impact factor: 4.388

Review 7.  Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Clin Cancer Res       Date:  2016-11-28       Impact factor: 12.531

Review 8.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

Review 9.  Pineal Gland Tumor Microenvironment.

Authors:  Joham Choque-Velasquez; Szymon Baluszek; Roberto Colasanti; Sajjad Muhammad; Juha Hernesniemi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas.

Authors:  Yanyu Zhang; Yuan Xie; Liqun He; Jiefu Tang; Qiyuan He; Qingze Cao; Langjun Cui; Wei Guo; Kai Hua; Anna Dimberg; Liang Wang; Lei Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-09-11       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.